QY Research, Inc.

Nuclear Medicine Market Will Surge at 7.4% CAGR to Reach 7580 Million US$ by the End of 2025: QY Research

QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

 

Los Angeles, CA -- (SBWIRE) -- 02/09/2019 -- The research study is a highly useful tool in the hands of market players that allows them to effectively assess the global Nuclear Medicine market and know where they stand in the industry in terms of revenue or sales growth. It comprehensively evaluates the global Nuclear Medicine market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects. Furthermore, it offers a precise account of key breakthroughs and developments taking shape in the global Nuclear Medicine market. It takes into consideration both the global and regional progress of the Nuclear Medicine market to provide a complete analysis.

The global Nuclear Medicine market is valued at 4590 million US$ in 2017 and will reach 7580 million US$ by the end of 2025, growing at a CAGR of 7.4% during 2018-2025.

This report studies the global Nuclear Medicine market status and forecast, categorizes the global Nuclear Medicine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.

Get PDF report template: https://www.qyresearch.com/sample-form/form/320281/global-nuclear-medicine-sales-market

Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.

The major players covered in this report

    GE Healthcare

    Bracco Imaging

    Mallinckrodt

    Lantheus Medical Imaging

    Bayer

    Triad Isotopes

    Nordion

    Jubilant Pharma

    Eli Lilly

    SIEMENS

    China Isotope & Radiation

    Dongcheng

How will the report be a powerful addition to your resources?
The all-inclusive analysis of the global Nuclear Medicine market provided in the research study can accelerate the decision-making process of players as it offers a clear explanation of market growth threats, opportunities, development status, and trends. Players can ensure positive results for their quarterly and yearly earnings with the help of the complete evaluation of the global Nuclear Medicine market provided in the report. Growth statistics and useful recommendations such as business expansion plans in developing regions included in the research study will enable players to expect more growth in the global Nuclear Medicine market.

Players can build effective long-term as well as short-term business strategies using the report. The analysts highlight industry trends, key marketing strategies used by leading companies, and business profile of top players operating in the global Nuclear Medicine market.

Access Full Comprehensive Industry Insights: 

https://www.qyresearch.com/settlement/pre/c0ee648d1bce2fd5771ccf52dc4400ca,0,1,Global%20Nuclear%20Medicine%20Sales%20Market%20Report%202018

Highlights from the TOC: 

Market Overview: Readers are provided with a brilliant overview of the global Nuclear Medicine market and the scope of products available for commercial sale. Here, the authors of the report also touch on key segments of the global Nuclear Medicine market and give a glimpse of the market size by value and volume.

Competition by Manufacturers: This section of the report shows how different manufacturers are performing in the global Nuclear Medicine market on the basis of average price, revenue, and production.
Production Market Share by Region: It includes market analysis of each region and country studied in the report in terms of gross margin, price, revenue, production, and growth rate.

Company Profiles and Key Figures in Business: It lists all players studied in the report on the basis of markets served, gross margin, price, revenue, production, product specification, application, and production sites.

Manufacturing Cost Analysis: It covers industrial chain analysis, raw material analysis, manufacturing cost structure, and other key aspects.

About Us: 
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US
QY Research, INC.
17890 Castleton, Suite 218,
Los Angeles, CA – 91748
USA: +1 6262 952 442
Emails – enquiry@qyresearch.com
Web – www.qyresearch.com